Clover Corporation Limited (CLV) Q2 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Thank you for standing by and welcome to the Global Corporation Limited 1H 2025 results call. All participants are in a listen-only mode. There will be a presentation followed by a question and answer session. If you wish to ask a question, you will need to press the star key followed by the number one on your telephone keypad. I would now like to hand the conference over to Mr. Peter Davey, Managing Director and CEO. Please go ahead. Good morning. Thank you, Harmony. Welcome to the Clover Corporation first half FY25 results presentation. My name is Peter Davey, the CEO of the company, and with me is Andrew Allibon, the CFO and Company Secretary. Andrew will take you through the financial components. If we go to the next slide. This is an addition for people that haven't known much about us in the past, a bit about the corporation. We develop and produce encapsulated bioactive ingredients specialising in high-value nutritional oils for infant formula, for medical foods and for functional foods. Effectively, what we have is encapsulation technology. We take highly valued bioactives and we turn them into powders, emulsions and oils that And then those products enable our customers to turn them into a finished product. So we really support our customers in creating a finished product and developing a solution for them. And I think as I walk through this presentation, you'll see that that's what stood us in very good stead in the marketplace over the last six months. In the first half of 2025, We had 60 employees in the company. We have seven offices around the world. We have 21 products that we sold in that first half. So different products. We have four manufacturing sites. We sold to 165 different customers across 40 different countries. That may vary in the second ha...